Compare
5 stocks, side by sideRelative performance · rebased to 100
IMTXCOAGAVLNJBIOSVRA
| IMTXImmatics N.V. | COAGHemab Therapeutics Holdings, Inc. | AVLNAvalyn Pharma Inc. | JBIOJade Biosciences, Inc. | SVRASavara Inc. | |
|---|---|---|---|---|---|
| Smart Score | 2/10 | - | - | 9/10 | 6/10 |
| Price | $9.52 | $27.72 | $28.98 | $21.81 | $6.03 |
| 1 month | -15% | -0.43% | +8.5% | +0.46% | +17% |
| 1 year | +75% | - | - | +108% | +164% |
| 5 year | -21% | - | - | - | +230% |
| P/E (TTM) | -6.1 | - | - | -10.2 | -9.5 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.